Summit Trail Advisors’s Steris STE Stock Holding History
Bought
Maintained
Sold
Other funds holding STE
OAG
GIM
Summit Trail Advisors's STE Position: Q2 2026 in Review
Summit Trail Advisors increased its Steris (STE) stake by 23% in Q2 2026, buying an estimated $315K and bringing the position to 7,880 shares worth $1.66M. The position accounts for 0.02% of the portfolio, ranked #723.
Summit Trail Advisors first reported a position in STE in Q4 2017 and has held it in 9 quarters since. 835 funds tracked by Wall St. Rank hold STE as of Q2 2026.
- Summit Trail Advisors held 7,880 shares of Steris worth $1.66M as of Q2 2026.
- Summit Trail Advisors bought 1,469 Steris shares in Q2 2026, an estimated $315K.
- Steris made up 0.02% of Summit Trail Advisors's portfolio in Q2 2026, its #723 holding.
- Summit Trail Advisors first reported a position in Steris in Q4 2017 and has held it in 9 quarters since.
- 835 funds tracked by Wall St. Rank held Steris as of Q2 2026.
Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.